Skip to main content
28 March 2024
Last updated:
Tuesday 26 March 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Diabetes reimbursement at risk in Germany
Read more
Unitary patent - for better or for worse?
Read more
2012 was the year of the antibody developer
Read more
Sofinnova's Investment Strategy: Putting the entrepreneur first
Read more
Are botanical drugs a new model for pharma?
Read more
Managers ignore pharmacovigilance at their peril
Read more
Adaptive licensing: A new approach for drug approvals
Read more
IMI: As Big Pharma pulls back, IMI steps in
Read more
MRC Technology: Going global for local returns
Read more
EU Transparency Directive: changes afoot on pricing and reimbursement
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
55
Page
56
Page
57
Page
58
Current page
59
Page
60
Page
61
Page
62
Page
63
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form